Terumo : expands global presence with new subsidiary in South-Africa
November 30, 2023 at 04:06 am EST
Share
November 30, 2023
Johannesburg, South-Africa - Terumo Corporation (TSE: 4543) today announced the establishment of Terumo South Africa (Pty) Ltd. (Terumo South Africa), its newest subsidiary in South-Africa. This strategic move represents a significant milestone in the company's continued commitment to expanding its global footprint and strengthening its presence in key growing markets.
Terumo South Africa, established as a wholly owned subsidiary of Terumo Europe and located in the heart of Johannesburg, will serve as a vital hub for Terumo to directly connect with local partners, better serve its growing customer base, and meet the healthcare needs and demands of South-Africa by providing tailored solutions, localized support, and rapid responses to the ever-evolving market conditions.
It is a first step in developing the company's footprint in Africa to further strengthen its presence on the continent.
Takuya Hosogai, President and CEO of Terumo Europe, said, "The opening of our new subsidiary in South-Africa is a step forward in realising our global Growth Strategy. We are dedicated to delivering exceptional value to our South-African partners, customers, and the patients they serve."
Khalil Aswad, General Manager, Africa, Terumo Interventional Systems, added, "Opening Terumo South Africa will enable us to engage closely with our customers, understanding their unique requirements and contributing to the local society through healthcare."
Terumo Corporation published this content on 30 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 November 2023 09:05:14 UTC.
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (53.5%);
- medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments (17.9%).
Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).
TERUMO CORPORATION 
